Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi V Russell

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Pediatrics|December 26, 2012
Economic evaluation of pediatric cancer treatment: a systematic literature reviewHeidi V Russell, Janki Panchal, Helena Vonville, et al.
World Journal of Gastroenterology|August 23, 2008
Diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcomaRyan W Himes, Isaac Raijman, Milton J Finegold, et al.
Pediatric Blood & Cancer|August 4, 2005
The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastomaHeidi V Russell, Laurie A Golding, Mary Nell Suell, et al.
Pediatric Hematology and Oncology|December 13, 2019
Blood product administration during high risk neuroblastoma therapyAllison Silverstein, Kiranmye Reddy, Valeria Smith, et al.
Pediatric Blood & Cancer|September 17, 2015
Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma?Jody L Lin, R Paul Guillerman, Heidi V Russell, et al.
Journal of Voice : Official Journal of the Voice Foundation|April 25, 2024
Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory PapillomatosisAri D Schuman, Alyssa C Chapel, Peng You, et al.
Pediatric Blood & Cancer|July 9, 2015
Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implicationsRachel S Beaty, M Brooke Bernhardt, Amanda H Berger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 2, 2007
Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactinHeidi V Russell, Douglas Strother, Zhuyong Mei, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastomaHeidi V Russell, Douglas Strother, Zhuyong Mei, et al.
Journal of Pediatric Hematology/Oncology|July 5, 2007
A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRTChrystal U Louis, Arnold C Paulino, Stephen Gottschalk, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Pediatrics|December 26, 2012
Economic evaluation of pediatric cancer treatment: a systematic literature reviewHeidi V Russell, Janki Panchal, Helena Vonville, et al.
World Journal of Gastroenterology|August 23, 2008
Diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcomaRyan W Himes, Isaac Raijman, Milton J Finegold, et al.
Pediatric Blood & Cancer|August 4, 2005
The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastomaHeidi V Russell, Laurie A Golding, Mary Nell Suell, et al.
Pediatric Hematology and Oncology|December 13, 2019
Blood product administration during high risk neuroblastoma therapyAllison Silverstein, Kiranmye Reddy, Valeria Smith, et al.
Pediatric Blood & Cancer|September 17, 2015
Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma?Jody L Lin, R Paul Guillerman, Heidi V Russell, et al.
Journal of Voice : Official Journal of the Voice Foundation|April 25, 2024
Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory PapillomatosisAri D Schuman, Alyssa C Chapel, Peng You, et al.
Pediatric Blood & Cancer|July 9, 2015
Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implicationsRachel S Beaty, M Brooke Bernhardt, Amanda H Berger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 2, 2007
Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactinHeidi V Russell, Douglas Strother, Zhuyong Mei, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastomaHeidi V Russell, Douglas Strother, Zhuyong Mei, et al.
Journal of Pediatric Hematology/Oncology|July 5, 2007
A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRTChrystal U Louis, Arnold C Paulino, Stephen Gottschalk, et al.
Pageof 5